narc01 – Awareness video about Narconon and their Narconon Arrowhead location in: Canadian, Oklahoma. Many people have senselessly died in the facility throughout the years of operation under the care of Narconon – a Scientology-based facility that uses the “teachings” of L. Ron Hubbard; a Science-Fiction writer & author of ‘Dianetics’. After the release of ‘Dianetics’, L. Ron Hubbard created a “religion” called Scientology. Too many people; mostly young people. The question that remains is…WHY?!? Fact: L. Ron Hubbard stated that he was against psychiatric drugs. Upon his death, the toxicology report & coroner’s report states that there was the presence of Vistaril (hydroxyzine) in Hubbard’s system. The most common use of Vistaril is for psychiatric problems. Scientology beliefs are against psychiatry, psychologists, psychiatric care, and psychiatric medication usage. L. Ron Hubbard stated that in his past…he had been a world traveler, lied about his military credentials; as well as other grandiose lies. I urge you to view BOTH sides of Scientology – online and/or with other reading material & sources as to prevent any bias. L.Ron Hubbard, and Narconon Arrowhead. The purpose of this video is to educate, inform, and create general public awareness about the MANY people that have lost a loved one that had been in Narconon’s care in their drug-free drug treatment program. Another sort of spinoff of Narconon is called Criminon. A program that claims to “rehabilitate” prisoners …
Greater Cleveland Drug Court receives 5000 grant to expand outreach …
Filed under:drug treatment programs
The grant money can only be used to treat people with substance abuse issues. The cost to incarcerate an offender is more than $ 20,000 per year, but the cost for the drug program is about $ 3,900, according to drug court officials. Cleveland Municipal … Read more on Plain Dealer
Drug May Limit Brain Damage After Stroke
Filed under:drug treatment programs
"Only after such trials will we know whether NA-1, ginsenoside-Rd, edaravone, or some other drug is the long-awaited holy grail for the treatment of patients with ischemic stroke," Kaste wrote. "The door is now reopening for new neuroprotection trials … Read more on MedPage Today